Jazz Pharmaceuticals JAZZ Unrecognized tax benefits, settlements
Unrecognized tax benefits, settlements at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's unrecognized tax benefits, settlements.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's unrecognized tax benefits, settlements?
- Jazz Pharmaceuticals (JAZZ) reported unrecognized tax benefits, settlements of $0 in Q4 2025.
- How has Jazz Pharmaceuticals's unrecognized tax benefits, settlements changed year-over-year?
- Jazz Pharmaceuticals's unrecognized tax benefits, settlements decreased by 100.0% year-over-year, from $651.25K to $0.
- What is the long-term trend for Jazz Pharmaceuticals's unrecognized tax benefits, settlements?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's unrecognized tax benefits, settlements has grown at a -100.0% compound annual growth rate (CAGR), from $14.74M to $0.
- What does unrecognized tax benefits, settlements mean?
- The reduction in tax uncertainty due to a formal settlement with tax authorities.
- How do you interpret unrecognized tax benefits, settlements?
- Settlements provide clarity and remove the uncertainty associated with a specific tax position, though they may involve cash outflows.
- How does unrecognized tax benefits, settlements compare across companies?
- Investors monitor this to understand the ultimate cost of tax disputes compared to the reserves previously established.